Atrial Fibrillation Management and Outcomes

Atrial fibrillation is an irregular heart rhythm in which the upper chambers of the heart beat chaotically, raising the risk of blood clots forming and traveling to the brain to cause stroke. Researchers in this area study how to reduce that risk through anticoagulant medications—comparing older drugs like warfarin against newer agents such as rivaroxaban and dabigatran—and through procedures like catheter ablation, which uses targeted energy to disrupt the abnormal electrical signals driving the arrhythmia. A central challenge is risk stratification: identifying which patients face enough danger from stroke or bleeding to justify aggressive treatment, and which can be managed more conservatively. Active questions include how to optimize long-term outcomes after ablation, how to personalize anticoagulation in patients with competing risks, and how clinical guidelines should evolve as trial evidence accumulates.

Works

150,452

Total citations

2,328,296

Keywords

Atrial FibrillationAnticoagulant TherapyCatheter AblationStroke PreventionRisk StratificationGuidelines